Fixed dose combinations of antihypertensive drugs and management of risk of development nephropathy in type 2 diabetes mellitus
Fomin, V.V.
Kardiologiia 52(10): 81-85
2012
ISSN/ISBN: 0022-9040 PMID: 23098355 Document Number: 662014
Document emailed within 1 workday
Related Documents
Kobalava, Z.D.; Kotovskaia, I.V.; Lobzhanidze, T.V.; Kravtsova, O.A. 2014: Optimization of arterial hypertension management by the use of two- and three-drugs fixed dose combinations at the daily stay department Kardiologiia 54(7): 17-24Dechend, R.; Derer, W.; Müller, D.N. 2009: Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component? MMW Fortschritte der Medizin 151(45): 46-47
Krairittichai, U.; Potisat, S.; Jongsareejit, A.; Sattaputh, C. 2011: Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 94(Suppl 2): S1-S5
Chantrel, F.; Bouiller, M.; Kolb, I.; Hannedouche, T. 2000: Antihypertensive treatment in type II diabetes and diabetic nephropathy Nephrologie 21(2): 47-55
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Laganović, M. 2010: Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension Lijecnicki Vjesnik 132(3-4): 94-98
Galicka-Latała, D.; Fedak, D.; Kuźniewski, M.; Kawalec, E.; Solnica, B. 2004: Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus Przeglad Lekarski 61(3): 155-158
Bayazit, A.K.; Yüksel, B.; Noyan, A.ül.; Onenli, N.; Gönlüşen, G.ül.; Ozer, G.ül.; Anarat, A. 2003: Early onset of diabetic nephropathy in a child with type 1 diabetes mellitus Turkish Journal of Pediatrics 45(1): 55-58
Boucek, P. 2006: Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system Vnitrni Lekarstvi 52(9): 791-796
Umemura, S. 2011: Advantage and disadvantages of single-pill (fixed) antihypertensive drug combinations Nihon Rinsho. Japanese Journal of Clinical Medicine 69(11): 2042-2048
Chiasera, J.M.; Ward-Cook, K.M.; McCune, S.A.; Wardlaw, G.M. 2000: Effect of aerobic training on diabetic nephropathy in a rat model of type 2 diabetes mellitus Annals of Clinical and Laboratory Science 30(4): 346-353
Abbas, S.; Raza, S.T.; S Mir, S.; Siddiqi, Z.; Mahdi, F. 2019: No association of SNP 313A→G in GSTP1 with nephropathy, hypertension and dyslipidemia in type 2 diabetes mellitus British Journal of Biomedical Science 76(3): 153-155
Statsenko, M.E.; Derevianchenko, M.V.; Ostrovskiĭ, O.V.; Titarenko, M.N.; Shvets, M.K.; Bondarev, A.M. 2013: Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus Terapevticheskii Arkhiv 85(9): 63-68
Statsenko, M.E.; Derevianchenko, M.V. 2014: Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy Terapevticheskii Arkhiv 86(8): 90-93
Onuchin, S.G.; Elsukova, O.S.; Solov'ev, O.V.; Onuchina, E.L. 2010: Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy Klinicheskaia Meditsina 88(1): 32-37
Krairittichai, U.; Chaisuvannarat, V. 2009: Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy Journal of the Medical Association of Thailand 92(5): 611-617
Singh, A.; Kalita, B.Chandra. 2020: A Study of Association of XBAI GLUT1 Gene Polymorphism in Patients of Type 2 Diabetes Mellitus with Diabetic Nephropathy Journal of the Association of Physicians of India 68(1): 50
Kazakova, I.A.; Trusov, V.V.; Cheremiskina, I.B. 2003: Clinical significance of assessment of the metabolism of connective-tissue biopolymers in patients with type 1 diabetes mellitus and with diabetic nephropathy Klinicheskaia Laboratornaia Diagnostika 10: 19-22
Davis, T.M.; Millns, H.; Stratton, I.M.; Holman, R.R.; Turner, R.C. 1999: Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29 Archives of Internal Medicine 159(10): 1097-1103
Zhang, S.; Dong, W.L.; Mao, F.; Jiang, Y.Y.; Wu, L.; Lou, Q.L.; Wu, H.D.; Zhang, Y.Q.; Ma, S.N.; Ren, Z.P.; Dong, J.Q. 2019: Effect of intervention programs regarding community "5+1" staged diabetes target management on patients with type 2 diabetes mellitus Zhonghua Liu Xing Bing Xue Za Zhi 40(2): 170-174